3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Interventions
Paclitaxel
57
Carboplatin
51
Bevacizumab
41
Taxes
28
liposomal doxorubicin
21
Gemcitabine
19
Immunoglobulin G
17
Disulfides
17
pembrolizumab
15
Topotecan
12
rucaparib
10
Cyclophosphamide
9
Cisplatin
9
Docetaxel
8
olaparib
7
Doxorubicin
7
pazopanib
6
mirvetuximab soravtansine
6
cediranib
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
sargramostim
4
niraparib
4
Surgical Procedures, Operative
4
Drug Therapy
4
Cytoreduction Surgical Procedures
4
Albumin-Bound Paclitaxel
4
veliparib
3
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Fallopian Tube Neoplasms
×
Pharmaceutical Preparations
×
Clear all
No trials found.